← FDA DRUG APPROVALS

FDA ANDA · ANDA062905

CLINDAMYCIN PHOSPHATE

Sponsor: LOCH

APPLICATION
ANDA062905
TYPE
ANDA
ORIGINAL APPROVAL
1988-05-09
LATEST ACTION
1993-01-29
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CLINDAMYCIN PHOSPHATEDiscontinued
CLINDAMYCIN PHOSPHATE EQ 150MG BASE/ML · INJECTABLE · INJECTION

Approval history

1993-01-29Labeling · Supplement 7AP
1989-07-13Manufacturing (CMC) · Supplement 3AP
1988-09-28Manufacturing (CMC) · Supplement 1AP
1988-05-09OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →